Get started
Author

Johann Bichler

Safety and Efficacy of Privigen®, a Novel 10% Liquid Immunoglobulin Preparation for Intravenous Use, in Patients with Primary Immunodeficiencies
2008 · Mark R. Stein, Robert P. Nelson, et al. · Journal of Clinical Immunology · 95
PDF
A single recombinant anti-RhD IgG prevents RhD immunization: association of RhD-positive red blood cell clearance rate with polymorphisms in the FcγRIIA and FcγIIIA genes
2004 · Sylvia Miescher, Martin O. Spycher, et al. · Blood · 91
Biologic effects of recombinant hirudin (CGP 39393) in human volunteers
1993 · Marc Verstraete, Mike Nurmohamed, et al. · Journal of the American College of Cardiology · 70
PDF
Detection of Thrombin in Human Blood by Ex-vivo Hirudin
1996 · Johann Bichler, John A. Heit, et al. · Thrombosis Research · 59
Pharmacokinetics of anti‐D IgG in pregnant RhD‐negative women
2003 · Johann Bichler, Georg Schöndorfer, et al. · BJOG An International Journal of Obstetrics & Gynaecology · 58
CHO expression of a novel human recombinant IgG1 anti-RhD antibody isolated by phage display
2000 · Sylvia Miescher, Monique Zahn-Zabal, et al. · British Journal of Haematology · 55
Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency
2009 · Richard L. Wasserman, Joseph A. Church, et al. · European Journal of Pharmaceutical Sciences · 50
Gating of thrombin in platelet aggregates by pO2-linked lowering of extracellular Ca2+ concentration
1995 · Whyte G. Owen, Johann Bichler, et al. · Biochemistry · 32
Efficacy and safety of simoctocog alfa (Nuwiq®) in patients with severe hemophilia A: a review of clinical trial data from the GENA program
2019 · Toshko Lissitchkov, Anna Klukowska, et al. · Therapeutic Advances in Hematology · 27
PDF
Efficacy and safety of a new, chromatographically purified rhesus (D) immunoglobulin
2004 · Ian Z. MacKenzie, Johann Bichler, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 26
Carimune NF Liquid is a Safe and Effective Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency Diseases
2007 · Melvin Berger, Charlotte Cunningham-Rundles, et al. · Journal of Clinical Immunology · 23
Safety, pharmacokinetics and efficacy of a subcutaneous recombinant FVIII (OCTA101) in adult patients with severe haemophilia A
2023 · Toshko Lissitchkov, Martina Jansen, et al. · Haemophilia · 2
Delayed Treatment with Desulfato-Hirudin Prevents Fibrin Formation in Lipopolysaccharide-Induced Shock
1997 · Matthias Siebeck, Michael Spannagl, et al. · Thrombosis Research · 2
Personalized Prophylaxis with Human-Cl Recombinant FVIII in HA Patients
2015 · Robert Klamroth, Toshko Lissitchkov, et al. · Blood · 1
Consumption Of FVIII Concentrate During On-Demand and Prophylactic Treatment With Human-cl rhFVIII In Prospective Clinical Studies In Adult Patients With Severe Hemophilia A
2013 · Andreas Tiede, Sigurd Knaub, et al. · Blood · 1
Thrombin Generation and Bleeding Phenotype during Personalized Prophylaxis with Recombinant Human FVIII in Previously Treated Patients with Severe Hemophilia A
2016 · Yesim G. Dargaud, Robert Klamroth, et al. · Blood
Human-Cl Rhfviii Effectively and Safely Prevents Bleeding Episodes in Previously Treated Adult Patients with Severe Haemophilia A
2012 · Sigurd Knaub, Toshko Lissitchkov, et al. · Blood
Works count: 17
Citation count: 592
H-index: 11
I10-index: 11
Year
Topic
Type